CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a 2-part, 2-arm, Phase 2 , multicentre, randomized, double-blind, placebo-controlled study in adults with COVID-19 with gas...
Phase 2
Birmingham, Alabama, United States of America and 24 other locations
This study is designed to demonstrate the performance and usability of the the Panbio™ COVID-19/Flu A&B Panel Self Test in the hand...
Pelham, Alabama, United States and 1 other location
The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...
Phase 3
Vestavia Hills, Alabama, United States and 217 other locations
This is a clinical trial to evaluate the safety, PK, viral shedding and clinical effects of Pentarlandir™ UPPTA in patients with early COVID-...
Phase 2
Cullman, Alabama, United States of America and 11 other locations
Study of EDP-235 in Non-hospitalized Adults with Mild or Moderate COVID-19....
Phase 2
Birmingham, Alabama, United States and 20 other locations
Performance of the LumiraDx SARS-CoV-2 Ag ULTRA assay will be assessed by comparison to a reference method
Birmingham, Alabama, United States and 5 other locations
be tolerated for treatment of pregnant women with mild or moderate COVID-19 compared to non-pregnant women with mild or moderate CO-...
Phase 1
Birmingham, Alabama, United States and 32 other locations
known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...
Phase 2, Phase 3
Birmingham, Alabama, United States and 214 other locations
The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vacci-...
Phase 3
Birmingham, Alabama, United States and 158 other locations
The purpose of this Phase III study is to assess the efficacy, safety, and immunogenicity of two CoV2 preS dTM-AS03 vaccines (monovalent and bivalent...
Phase 3
Birmingham, Alabama, United States and 93 other locations
Clinical trials
Research sites
Resources
Legal